$2.470
-0.105 (-4.26%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
XTLB Prediction & Forecast by Similar Chart Analysis
Alphio's XTLB stock price prediction model matches the current X T L Biopharmaceuticals Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.49 (+1.01%). The 1-week path is $2.50 (+1.05%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy X T L Biopharmaceuticals Ltd Stock?
XTL Biopharmaceuticals Ltd is not a good buy right now due to its current price of $2.47 and a concerning RSI of 30.106, indicating oversold conditions. The company is facing serious risks, including a Nasdaq compliance notice for failing to meet minimum shareholder equity requirements, which could lead to delisting. Additionally, the stock has experienced a 48.11% decline over the past year, reflecting ongoing financial instability.
XTLB stock price ended at $2.47 on Friday, after losing -4.26%
X T L Biopharmaceuticals Ltd (XTLB) last closed at $2.47, losing -4.26%. These facts feed the 1-day and 1-week XTLB price prediction above.
Forecast Drivers
X T L Biopharmaceuticals Ltd (XTLB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches XTLB, ranked by similarity.
Seasonality analysis for XTLB
Historically the probability of a positive August return for XTLB is 66.67%. July offers the highest probability of a positive month at 66.67%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for XTLB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.81 | $1.97 | $2.04 | -20.06% |
| Sep 2026 | $1.53 | $1.57 | $1.73 | -36.40% |
| Oct 2026 | $1.26 | $1.59 | $1.85 | -35.65% |
| Nov 2026 | $1.86 | $1.91 | $2.28 | -22.53% |
| Dec 2026 | $2.08 | $2.09 | $2.34 | -15.48% |
In 2026, X T L Biopharmaceuticals Ltd (XTLB) is projected to range from $1.26 to $2.34.
X T L Biopharmaceuticals Ltd 2026 monthly forecast
In Aug 2026, X T L Biopharmaceuticals Ltd is projected to average $1.97, with a low of $1.81 and high of $2.04.
In Sep 2026, X T L Biopharmaceuticals Ltd is projected to average $1.57, with a low of $1.53 and high of $1.73.
In Oct 2026, X T L Biopharmaceuticals Ltd is projected to average $1.59, with a low of $1.26 and high of $1.85.
In Nov 2026, X T L Biopharmaceuticals Ltd is projected to average $1.91, with a low of $1.86 and high of $2.28.
In Dec 2026, X T L Biopharmaceuticals Ltd is projected to average $2.09, with a low of $2.08 and high of $2.34.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.